CBD Medication Gets Initial Acceptance From US Health Officials

A pharmaceutical drug utilizing a non-psychoactive cannabis compound was given a boost in support from American health officials this week, bringing the naturally-derived cannabidiol (CBD) medication one-step closer to total approval from the Food and Drug Administration (FDA).

According to the New York Times, Epidiolex — a seizure-reducing CBD liquid made by British drug firm GW Pharmaceuticals — was given a vote of support in a new FDA Briefing Document released Tuesday, in which members of the federal agency reported positive trials and suggested the drug be approved by the FDA at large.

CBD, a chemical compound found in the cannabis plant that does not have psychoactive effects, has been used to treat a seizures and other ailments in both children and adults for decades. Currently, CBD is sold in both medical and recreational marijuana markets across the country, including a hemp derivative that can be found in health food

... read more at: https://merryjane.com/food/cbd-medication-gets-initial-acceptance-from-us-health-officials